Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Tesla
TSLA
|
+$402M |
| 4 |
NVIDIA
NVDA
|
+$372M |
| 5 |
AT&T
T
|
+$323M |
Top Sells
| 1 |
Cisco
CSCO
|
+$489M |
| 2 |
Broadcom
AVGO
|
+$428M |
| 3 |
Apple
AAPL
|
+$424M |
| 4 |
Netflix
NFLX
|
+$422M |
| 5 |
CELG
Celgene Corp
CELG
|
+$421M |
Sector Composition
| 1 | Technology | 20.52% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Great Southern Bancorp
GSBC
$721M
| $3.48M | ﹤0.01% |
54,916
+11,379
| +26% | +$720K |
|
|
GTHX
2177
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.48M | ﹤0.01% |
131,547
-1,841
| -1% | -$48.6K |
|
|
PEI
2178
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $3.48M | ﹤0.01% |
20,556
| – | – |
|
2179
Gerdau
GGB
$6.21B
| $3.46M | ﹤0.01% |
890,552
-1,790,014
| -67% | -$6.96M |
|
2180
Triumph Financial, Inc.
TFIN
$1.35B
| $3.46M | ﹤0.01% |
90,937
-47
| -0.1% | -$1.79K |
|
|
BFYT
2181
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.46M | ﹤0.01% |
179,151
-236,353
| -57% | -$4.56M |
|
|
EVOP
2182
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $3.44M | ﹤0.01% |
130,270
-63,095
| -33% | -$1.67M |
|
2183
Alaunos Therapeutics
TCRT
$5.25M
| $3.44M | ﹤0.01% |
4,852
-52
| -1% | -$36.8K |
|
2184
Franklin Covey
FC
$246M
| $3.43M | ﹤0.01% |
106,471
+64,818
| +156% | +$2.09M |
|
2185
Unilever
UL
$156B
| $3.43M | ﹤0.01% |
59,999
+110
| +0.2% | +$6.29K |
|
|
AXNX
2186
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.41M | ﹤0.01% |
122,878
+59,140
| +93% | +$1.64M |
|
2187
Pitney Bowes
PBI
$1.97B
| $3.4M | ﹤0.01% |
844,463
-11,024
| -1% | -$44.4K |
|
2188
Arlo Technologies
ARLO
$1.81B
| $3.4M | ﹤0.01% |
807,072
+382,235
| +90% | +$1.61M |
|
2189
MGP Ingredients
MGPI
$603M
| $3.39M | ﹤0.01% |
69,989
+9,216
| +15% | +$447K |
|
2190
Innovative Industrial Properties
IIPR
$1.6B
| $3.38M | ﹤0.01% |
44,494
-1,269
| -3% | -$96.3K |
|
|
JOBS
2191
DELISTED
51job, Inc.
JOBS
| $3.37M | ﹤0.01% |
39,720
-92
| -0.2% | -$7.81K |
|
|
CHCT
2192
Community Healthcare Trust
CHCT
$446M
| $3.36M | ﹤0.01% |
78,503
+5,353
| +7% | +$229K |
|
|
MSGN
2193
DELISTED
MSG Networks Inc.
MSGN
| $3.36M | ﹤0.01% |
193,062
-478,126
| -71% | -$8.32M |
|
|
CURO
2194
DELISTED
CURO Group Holdings Corp.
CURO
| $3.36M | ﹤0.01% |
275,509
+33,099
| +14% | +$403K |
|
2195
National Research Corp
NRC
$374M
| $3.35M | ﹤0.01% |
50,756
-1,119
| -2% | -$73.8K |
|
2196
Gorman-Rupp
GRC
$1.15B
| $3.34M | ﹤0.01% |
89,072
-1,799
| -2% | -$67.5K |
|
|
IMGN
2197
DELISTED
Immunogen Inc
IMGN
| $3.34M | ﹤0.01% |
653,757
-35,188
| -5% | -$180K |
|
|
CPLG
2198
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $3.34M | ﹤0.01% |
312,388
-560
| -0.2% | -$5.98K |
|
|
TRHC
2199
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $3.33M | ﹤0.01% |
68,357
-1,136
| -2% | -$55.3K |
|
|
CIR
2200
DELISTED
CIRCOR International, Inc
CIR
| $3.33M | ﹤0.01% |
71,930
-1,345
| -2% | -$62.2K |
|